Literature DB >> 26672910

Is inflammatory bowel disease in dogs and cats associated with a Th1 or Th2 polarization?

Romy M Heilmann1, Jan S Suchodolski2.   

Abstract

Mucosal immunity involves complex interactions to generate either immune tolerance or active immune responses. An imbalance of pro- and anti-inflammatory cytokines and chemokines that drive the recruitment of immune cells to the intestinal mucosa are a key characteristic of inflammatory bowel disease in humans, where distinctive helper-T-lymphocyte profiles help to discriminate between Crohn's disease and ulcerative colitis. This review evaluates the current veterinary literature to determine whether a Th1/Th2 (and possibly also Th17) polarization also exists in canine and feline inflammatory bowel disease.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Canine; Chronic enteropathy; Inflammatory bowel disease; Th1; Th17; Th2

Mesh:

Year:  2015        PMID: 26672910     DOI: 10.1016/j.vetimm.2015.10.008

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  13 in total

1.  Association between serum soluble receptor for advanced glycation end-products (RAGE) deficiency and severity of clinicopathologic evidence of canine chronic inflammatory enteropathy.

Authors:  Angela Isabel Cabrera-García; Jan S Suchodolski; Jörg M Steiner; Romy M Heilmann
Journal:  J Vet Diagn Invest       Date:  2020-07-27       Impact factor: 1.279

Review 2.  Nonpharmacological Treatment Strategies for the Management of Canine Chronic Inflammatory Enteropathy-A Narrative Review.

Authors:  Marco Isidori; Ronald Jan Corbee; Massimo Trabalza-Marinucci
Journal:  Vet Sci       Date:  2022-01-20

3.  Expression of Treg/Th17 cells as well as related cytokines in patients with inflammatory bowel disease.

Authors:  Xianhui Geng; Jie Xue
Journal:  Pak J Med Sci       Date:  2016 Sep-Oct       Impact factor: 1.088

4.  Regulatory role of NKG2D+ NK cells in intestinal lamina propria by secreting double-edged Th1 cytokines in ulcerative colitis.

Authors:  Fan Wang; Pai-Lan Peng; Xue Lin; Ying Chang; Jing Liu; Rui Zhou; Jia-Yan Nie; Wei-Guo Dong; Qiu Zhao; Jin Li
Journal:  Oncotarget       Date:  2017-10-30

5.  Expression of epithelial cell-derived cytokine genes in the duodenal and colonic mucosae of dogs with chronic enteropathy.

Authors:  Hironari Osada; Misato Ogawa; Ayana Hasegawa; Makoto Nagai; Junsuke Shirai; Kazuaki Sasaki; Minoru Shimoda; Hiroshi Itoh; Hirotaka Kondo; Keitaro Ohmori
Journal:  J Vet Med Sci       Date:  2016-12-29       Impact factor: 1.267

6.  Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies.

Authors:  Romy M Heilmann; Nora Berghoff; Joanne Mansell; Niels Grützner; Nolie K Parnell; Corinne Gurtner; Jan S Suchodolski; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2018-02-20       Impact factor: 3.333

7.  Interleukin-13 and interleukin-33 mRNA are underexpressed in the duodenal mucosa of German Shepherd dogs with chronic enteropathy.

Authors:  Aarti Kathrani; Victor Lezcano; Edward J Hall; Albert E Jergens; Yeon-Jung Seo; Jonathan P Mochel; Todd Atherly; Karin Allenspach
Journal:  J Vet Intern Med       Date:  2019-06-06       Impact factor: 3.333

8.  Interleukin-1β expression is increased in the duodenum of dogs with idiopathic inflammatory bowel disease.

Authors:  Martin Hawes; Anna Riddle; Joseph Kirk; Albert Jergens; Karin Allenspach
Journal:  Vet Rec       Date:  2018-05-09       Impact factor: 2.695

Review 9.  Clinical utility of currently available biomarkers in inflammatory enteropathies of dogs.

Authors:  Romy M Heilmann; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2018-09-17       Impact factor: 3.333

Review 10.  What are the potential biomarkers that should be considered in diagnosing and managing canine chronic inflammatory enteropathies?

Authors:  Carina Sacoor; Luís Meireles Barros; Liliana Montezinho
Journal:  Open Vet J       Date:  2020-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.